These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37143703)

  • 1. Diagnostic Performance of Anti-Topoisomerase-I, Anti-Th/To Antibody and Anti-Fibrillarin Using Immunoblot Method in Systemic Sclerosis Related Interstitial Lung Disease Patients.
    Logito V; Tjandrawati A; Sugianli AK; Tristina N; Dewi S
    Open Access Rheumatol; 2023; 15():43-49. PubMed ID: 37143703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
    Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
    J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
    Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
    PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary manifestations and prognosis of a cohort of patients with interstitial lung disease and positive to anti-Th/To autoantibodies.
    Mejía M; Ramos-Martínez E; Vázquez-Becerra LE; Fernández-Badillo D; Mateos-Toledo HN; Castillo J; Estrada A; Rojas-Serrano J
    Med Clin (Barc); 2024 Apr; 162(8):378-384. PubMed ID: 38290874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests.
    Alkema W; Koenen H; Kersten BE; Kaffa C; Dinnissen JWB; Damoiseaux JGMC; Joosten I; Driessen-Diks S; van der Molen RG; Vonk MC; Smeets RL
    Autoimmunity; 2021 May; 54(3):148-155. PubMed ID: 33818234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.
    Chatterjee S; Perelas A; Yadav R; Kirby DF; Singh A
    Clin Rheumatol; 2023 Mar; 42(3):653-661. PubMed ID: 36271064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Manifestation and Incidence of Cardiopulmonary Complications in Early Systemic Sclerosis Patients with Different Antibody Profiles.
    Wangkaew S; Prasertwittayakij N; Euathrongchit J
    J Clin Med Res; 2019 Jul; 11(7):524-531. PubMed ID: 31236172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis.
    Foeldvari I; Klotsche J; Hinrichs B; Helmus N; Kasapcopur O; Adrovic A; Sztajnbok F; Terreri MT; Anton J; Smith V; Katsicas M; Kostik M; Vasquez-Canizares N; Avcin T; Feldman B; Janarthanan M; Santos MJ; Sawhney S; Schonenberg-Meinema D; Sifuentes-Giraldo WA; Alexeeva E; Appenzeller S; Battagliotti C; Berntson L; Bica B; Costa-Reis P; Eleftheriou D; Kallinich T; Lehman T; Marrani E; Minden K; Nielsen S; Nuruzzaman F; Patwardhan A; Khubchandani R; Stanevicha V; Uziel Y; Torok KS
    Arthritis Care Res (Hoboken); 2022 Mar; 74(3):364-370. PubMed ID: 33141441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis.
    Bernstein EJ; Jaafar S; Assassi S; Domsic RT; Frech TM; Gordon JK; Broderick RJ; Hant FN; Hinchcliff ME; Shah AA; Shanmugam VK; Steen VD; Khanna D
    Arthritis Rheumatol; 2020 Nov; 72(11):1892-1896. PubMed ID: 32583956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.
    Barskova T; Gargani L; Guiducci S; Randone SB; Bruni C; Carnesecchi G; Conforti ML; Porta F; Pignone A; Caramella D; Picano E; Cerinic MM
    Ann Rheum Dis; 2013 Mar; 72(3):390-5. PubMed ID: 22589373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis.
    Qiu M; Nian X; Pang L; Yu P; Zou S
    Int J Rheum Dis; 2021 Dec; 24(12):1449-1459. PubMed ID: 34418313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
    Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
    Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis].
    Dol C; Granel B; Resseguier N; Kaplanski G; Reynaud-Gaubert M; Schleinitz N; Grob JJ; Delaporte E; Lafforgue P; Rossi P; Bardin N; Benyamine A
    Rev Med Interne; 2024 Mar; 45(3):126-131. PubMed ID: 38355359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Interstitial Lung Disease in Egyptian Patients with Systemic Sclerosis: Relation to Disease Parameters.
    Abdelati AA; Deghady AA; Abdelhady AM; Bastawy RA; Shaaban A
    Curr Rheumatol Rev; 2023; 19(2):189-196. PubMed ID: 35984025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of lung ultrasound to identify interstitial lung disease: An observational study based on the STROBE guidelines.
    Yan JH; Pan L; Gao YB; Cui GH; Wang YH
    Medicine (Baltimore); 2021 Mar; 100(12):e25217. PubMed ID: 33761708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study.
    Frauenfelder T; Winklehner A; Nguyen TD; Dobrota R; Baumueller S; Maurer B; Distler O
    Ann Rheum Dis; 2014 Dec; 73(12):2069-73. PubMed ID: 25269829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Interstitial Lung Disease Morphology Scores Based on High-resolution Computed Tomography Chest and Skin Fibrosis Degree Based on Modified Rodnan's Skin Score on Systemic Sclerosis.
    Hikmat IH; Ramdhini SS; Soekersi H; Dewi S
    Acta Med Indones; 2021 Jul; 53(3):254-260. PubMed ID: 34611063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.